Genes & biomarkers
NRAS variants
NRAS · RAS pathway
A biomarker may help rule out a treatment as well as select one.
Sources checked · Introductory guide
On this page
What does this result mean?
NRAS belongs to the same signaling family as KRAS. Variants can occur in colorectal cancer and melanoma; NRAS results should be checked separately from KRAS.[1]
How does it connect to treatment?
In metastatic colorectal cancer, RAS variants including NRAS help identify tumors unlikely to benefit from anti-EGFR treatment such as cetuximab. This rule is not identical for every cancer type.[2]
What should I check in my report?
Ask whether “RAS wild type” reflects testing of the required regions of both KRAS and NRAS. An NRAS finding alone does not select a specific direct inhibitor.
Questions for your care team
- How does my NRAS result affect anti-EGFR treatment?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.